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L E T T E R T O TH E E D I T O R
Nonsurgical genioplasty
Dear Editor,
Chin contributes to facial balance and harmony. Appropriate treat-
ment of aesthetic deformities of the will often improves the appear-
ance of the mouth, lips, and nose. Augmentation of the chin can be
performed with injectable fillers or autologous fat, placement of an
alloplastic chin implant, or with chin's bony osteotomy. Determining
the best procedure for a patient requires careful consideration of his
anatomy, as well as the risks and benefits of each treatment. Fillers
offer a nonsurgical, nonpermanent method of correction of chin
retrusion in the appropriate patient.
We describe a case series of 200 patients, which have been
treated with chin corrections by means of VYC-20 hyaluronic acid in
order to create a treatment algorithm for chin defects thereby record-
ing technique, amount of filler and complication rate in our patients.
Seckel divided the face into seven functional danger zones.
Danger Zone 3: Includes the marginal mandibular branch of the
facial nerve, facial artery, and vein.
Danger Zone 7: Contains the mental nerve, which carries sensory
innervation to ipsilateral chin and lower lip.
Focus on patient's examination. Preoperative photos were taken.
Stop all blood-thinning agents starting 1 week prior to the proce-
dure to reduce bruising.
The chin can be divided into six subunits using the MD Codes
classification. Volumizing a single area often leads to inadequate aes-
thetic results.
High G-prime, high viscosity hyaluronic acid (HA), was used. A
27-gauge needle can be used for deep injections subperiosteally, and
we advise using blunt cannula to make refinements. The bimodal
approach for filler injection into the chin can be beneficial doing deep
injections to augment the mandibular structure, followed by injections
in the subcutaneous fat layer to improve contouring. We used an
average of 4 mL of high G-prime HA per patient.
Immediately after procedure, we gave ice pack for 30 min.
We treated 200 patients (147 women, 53 men) aged 21–48 (aver-
age 34.6 years old).
Follow-up: after 3 days, 1 week, 1 month, and 8 months.
Clinical photos were taken 2 weeks and 8 months after procedure.
Side effects: see Table 1. Also, refer Figures 1 and 2.
HA fillers are used for their characteristics (Bertossi et al., 2013), if
the patient does not like the result or if there are adverse effects hyal-
uronidase can be used. At this point, a clear treatment plan is neces-
sary to justify the possible choices offered to our patients after our
clinical records.
In our study, we have used the Arnett's analysis (soft tissue cepha-
lometric analysis (STCA); Arnett & Gunson, 1993).
F IGURE 1 Before and after
hyaluronic acid filler (left-side after,
right-side before) frontal view
TABLE 1 Complications during nonsurgical genioplasty
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With regard to complications, the chin region is considered a safer
area, as very few cases of postfiller vascular complications have been
reported in literature, skin necrosis and lingual necrosis were the
worst.
Injection techniques such as pretunneling, use of a blunt cannula,
aspiration before injection, slow injection, low-pressure injection,
moving the needle while injecting, and use of a small bolus per injec-
tion should be applied to minimize complications. Close and consis-
tent observation of patients after filler injection is necessary. If signs
and symptoms are observed, the patient must return and undergo fur-
ther examination. Diagnosis and treatment should not be delayed.
The first-choice therapy for vascular occlusion due to HA is the
use of hyaluronidase, an enzyme that catalyzes HA hydrolysis. Treat-
ment is conducted with a focus on proper timing (DeLorenzi, 2017).
Hyaluronidase should be immediately injected into the affected area
once the diagnosis is confirmed (Fang, Rahman, & Kapoor, 2018), or
even suspected. Delayed injection will undoubtedly be an obstacle to
saving tissues from ischemia.
It is important to choose the right patient to maximize results and
give him a predictable and stable outcome (Bertossi et al., 2015; Guyuron &
Raszewski, 1990; Richard et al., 2001; Trauner & Obwegeser, 1957;
White & Dufresne, 2011). The best results arrive when:
• Low sagittal deficiency or with mild asymmetry, with normal, mild,
and reduction of soft-tissue chin thickness.
• Sagittal deficiency, with no asymmetry with mild or severe reduc-
tion of soft-tissue chin thickness.
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